BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium bifidum {B. bifidum} - Clostridium perfringens |
👶
[Effect of probiotic product containing bifidobacteria and biogel from brown algae on the intestinal microflora and parameters of innate immunity in mice with experimental drug dysbacteriosis]. Voprosy pitaniia (Vopr Pitan ) Vol: 84 Issue 1 Pages: 73-9 Pub: 2015 Epub: Authors Kuznetsova TA , Makarenkova ID , Koneva EL , Aminina NM , Yakush EV , |
| bifidobacterium bifidum {B. bifidum} - Clostridium perfringens |
👶
[Protective effect and mechanism of Bifidobacterium bifidum TMC3115 on long-term colitis in mice which exposed to antibiotic in early life]. Wei sheng yan jiu = Journal of hygiene research (Wei Sheng Yan Jiu ) Vol: 51 Issue 4 Pages: 624-644 Pub: 2022 Jul Epub: Authors Wang S , Peng C , Li J , Cheng R , He F , Yang L , Lu J , Shen X , Publication |
| bifidobacterium bifidum {B. bifidum} - Clostridium perfringens |
📓
Dietary Mannan-oligosaccharides potentiate the beneficial effects of Bifidobacterium bifidum in broiler chicken. Letters in applied microbiology (Lett Appl Microbiol ) Vol: 71 Issue 5 Pages: 520-530 Pub: 2020 Nov Epub: 2020 Aug 24 Authors Dev K , Akbar Mir N , Biswas A , Kannoujia J , Begum J , Kant R , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
